2013 Q3 Form 10-Q Financial Statement

#000119312513433236 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $40.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $36.00K
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$36.00K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$36.00K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share -$36.00
Diluted Earnings Per Share -$36.00
COMMON SHARES
Basic Shares Outstanding 1.000K shares
Diluted Shares Outstanding 1.000K shares

Balance Sheet

Concept 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $1.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $14.83K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $100.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $100.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $100.0K
Total Long-Term Liabilities $0.00
Total Liabilities $146.1K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $10.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$131.3K
YoY Change
Total Liabilities & Shareholders Equity $14.83K
YoY Change

Cashflow Statement

Concept 2013 Q3
OPERATING ACTIVITIES
Net Income -$36.00K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 0.000
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001571776
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7500000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
990
CY2013Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
105000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-131309
CY2013Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
41135
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
10
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14826
CY2013Q3 us-gaap Liabilities
Liabilities
146135
CY2013Q3 us-gaap Assets
Assets
14826
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14826
CY2013Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
132309
CY2013Q3 us-gaap Cash
Cash
14826
CY2013Q3 chmi Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
10000
CY2013Q3 chmi Additional Obligation Indirect Expenses
AdditionalObligationIndirectExpenses
0
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
990
CY2012Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
25000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-24000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
10
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1000
CY2012Q4 us-gaap Liabilities
Liabilities
25000
CY2012Q4 us-gaap Assets
Assets
1000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1000
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
25000
CY2012Q4 us-gaap Cash
Cash
1000
dei Entity Registrant Name
EntityRegistrantName
Cherry Hill Mortgage Investment Corporation
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
us-gaap Operations Commenced Date1
OperationsCommencedDate1
2013-10-09
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27309
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>Use of estimates</b></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the balance sheet, in addition to the reported amount revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation allowance on deferred tax assets.</p> </div>
us-gaap Equity Issuance Dates
EquityIssuanceDates
2013-10-04
us-gaap Net Income Loss
NetIncomeLoss
-107309
us-gaap Costs And Expenses
CostsAndExpenses
107309
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2309
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41135
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13826
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
80000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
41135
chmi Audit Fees
AuditFees
105000
chmi Initial Public Offering Cost Incurred By Manager
InitialPublicOfferingCostIncurredByManager
1600000
chmi Indirect Expenses Incurred By Manager
IndirectExpensesIncurredByManager
800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27309
us-gaap Net Income Loss
NetIncomeLoss
-132309
us-gaap Costs And Expenses
CostsAndExpenses
132309
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2309
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42135
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14826
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
105000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
41135
chmi Audit Fees
AuditFees
130000
chmi Indirect Expenses Incurred By Manager
IndirectExpensesIncurredByManager
840000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-25000
CY2012Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-36054
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
36054
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1054
CY2013Q3 chmi Audit Fees
AuditFees
35000

Files In Submission

Name View Source Status
0001193125-13-433236-index-headers.html Edgar Link pending
0001193125-13-433236-index.html Edgar Link pending
0001193125-13-433236.txt Edgar Link pending
0001193125-13-433236-xbrl.zip Edgar Link pending
chmi-20130930.xml Edgar Link completed
chmi-20130930.xsd Edgar Link pending
chmi-20130930_cal.xml Edgar Link unprocessable
chmi-20130930_def.xml Edgar Link unprocessable
chmi-20130930_lab.xml Edgar Link unprocessable
chmi-20130930_pre.xml Edgar Link unprocessable
d615889d10q.htm Edgar Link pending
d615889dex311.htm Edgar Link pending
d615889dex312.htm Edgar Link pending
d615889dex321.htm Edgar Link pending
d615889dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending